title: The future of cervical cancer prevention in Europe.
abstract: Cervical cancer remains a significant source of disease and death in Europe. However, we now have the means to prevent virtually every case of cervical cancer through comprehensive, population-based, organised cervical cancer prevention programmes that effectively integrate cervical screening with the new technologies and vaccines that are now available. Given the potential health benefits of these programmes in reducing disease incidence and mortality, their establishment is now an ethical imperative for all European countries.
authors.affiliation: European Cervical Cancer Association, Lyon, France. philip.davies@ecca.info
authors.forename: Philip
authors.initials: P
authors.lastname: Davies
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Bogdanovic-Guillion
authors.forename: Magdalena
authors.initials: M
authors.lastname: Grce
authors.forename: Hélène
authors.initials: H
authors.lastname: Sancho-Garnier
mesh_terms: D000328:Adult; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000517:prevention & control* / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines